12 reports

  • ENDOMETRIAL CANCER THERAPEUTICS, GLOBAL, CLINICAL TRIALS BY REGION (%), 2019*
  • ENDOMETRIAL CANCER THERAPEUTICS, G7 COUNTRIES, CLINICAL TRIALS BY TRIAL STATUS, 2019*

Endometrial Cancer Global Clinical Trials Review, H##, 2019 H e a l t h c a r e H e a l t h c a r e REFERENCE CODE: GDHC##CTIDB PUBLICATION DATE: MAY 2019 Mar ##, 2019: Compugen Presents Update on COM## Phase ## Trial at ASCO-SITC Clinical Immuno-Oncology LIST OF TABLES L

  • Drug Development
  • Endometrial Cancer
  • United States
  • World
  • Product Initiative
  • LATEST CLINICAL TRIALS NEWS ON ENDOMETRIAL CANCER
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF ENDOMETRIAL CANCER TO ONCOLOGY CLINICAL TRIALS

Endometrial Cancer clinical trial report consists of ## trials.

  • Clinical Trial
  • Drug Development
  • Endometrial Cancer
  • World
  • Product Initiative
  • Endometrial Cancer - Overview
  • Endometrial Cancer - Dormant Projects

Endometrial cancer is the most common type of uterine cancer.

  • Cancer
  • Endometrial Cancer
  • Hospital
  • Therapy
  • Merck & Co., Inc.

Endometrial Cancer Ongoing Global Clinical Trials Analysis and Outlook ## Table of Contents ##. ## List of Figures ##. ## List of Tables ## Key Findings, 2018 ##. ## Snapshot ##. ## Overview of Endometrial Cancer Trials ## Clinical Trials Trends to 2022 ##. ## Ongoing

  • Cancer
  • Clinical Trial
  • Drug Development
  • Endometrial Cancer
  • Pathology

Global Endometrial Cancer Therapeutics Market By Therapy, By Enduser, & Pipeline Analysis, Outlook to 2023 ##.

  • Endometrial Cancer
  • Therapy
  • United States
  • World
  • Company Financials
  • Endometrial Cancer - Discontinued Products
  • Endometrial Cancer - Overview

HOFFMANN-LA ROCHE LTD AVEO PHARMACEUTICALS INC BAYER AG BAYER AG BEIGENE LTD BEIGENE LTD BEIGENE LTD BEIGENE LTD CBT PHARMACEUTICALS INC ENDOMETRIAL CANCER ENDOMETRIAL CANCER ENDOMETRIAL CANCER ENDOMETRIAL CANCER

  • Endometrial Cancer
  • Hospital
  • Pharmaceutical
  • Therapy
  • Merck & Co., Inc.

2019 Endometrial Cancer Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 ##.

  • Cancer
  • Clinical Trial
  • Drug Development
  • Endometrial Cancer
  • Pathology

2019 Endometrial Cancer Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets ##.

  • Cancer
  • Clinical Trial
  • Drug Development
  • Endometrial Cancer
  • APAC
  • Clinical Trial profile. 31 Trial Title
  • Clinical Trial profile. 18 Trial Title

CLINICAL TRIALS BY PHASE IN E## COUNTRIES ENDOMETRIAL HYPERPLASIA THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2019* ENDOMETRIAL HYPERPLASIA THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2019* ENDOMETRIAL HYPERPLASIA THERAPEUTICS, E## COUNTRIES, CLINICAL TRI

  • Endometrial Cancer
  • Genitourinary System Disease
  • World
  • Product Initiative
  • Bayer AG
  • Clinical Trial profile. 10 Trial Title

CLINICAL TRIALS BY PHASE IN G## COUNTRIES ENDOMETRIAL HYPERPLASIA THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2017* ENDOMETRIAL HYPERPLASIA THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2017* ENDOMETRIAL HYPERPLASIA THERAPEUTICS, G## COUNTRIES, CLINICAL TRI

  • Drug Development
  • Endometrial Cancer
  • Pharmaceutical
  • World
  • Product Initiative
  • Clinical Trial profile. 1015 Trial Title
  • Clinical Trial profile. 462 Trial Title

Fulvestrant for the Treatment of Recurrent or Metastatic Endometrial Carcinoma.

  • Clinical Trial
  • Drug Development
  • Endometrial Cancer
  • World
  • Product Initiative
  • DIAGNOSTIC ASSAY - ENDOMETRIAL CANCER
  • Diagnostic Assay - Endometrial Cancer - Product Status

As of March, 2016 DIAGNOSTIC ASSAY - ENDOMETRIAL CANCER Diagnostic Assay - Endometrial Cancer Product Overview Diagnostic Assay - Endometrial Cancer - Product Status Developed By Pipeline Territory Highest Stage of Development Device Class Regulatory Path

  • Breast Cancer
  • Cancer
  • Endometrial Cancer
  • Genomics
  • Orion Genomics LLC